Lifeyear

Digital-first heart care. At scale.

More healthy life years

Digitally enabled care pathways for cardiovascular risk conditions.

Heart disease is the most prevalent and costly chronic disease

20 million

Cardiovascular disease causes 1 in 3 deaths globally. That’s 20 million deaths a year, or one death every 1.5 seconds.

$ 1 trillion

Costs to healthcare systems are expected to rise to $ 1 trillion by 2030.

1 in 3

1 in 3 adults globally are living with elevated risk of heart attack or stroke.

80%

80% of premature cardiac events could be prevented with earlier treatment.

Our mission

Our mission

We are on a mission to extend human healthspan.

Solution

Digital therapeutics

Precision treatment programs for cardiovascular risk conditions that improve clinical outcomes, make patient management more efficient and help reduce cost of care.

For patients

For patients

All-in-one tool for cardiovascular health

We empower patients to understand, track and self-manage their cardiovascular health.

  • 24/7 access to evidence-based care
  • Easy health monitoring
  • Engaging treatment programs
  • Reduced risk of cardiac events
  • Improved health related quality of life
For clinicians

For clinicians

Evidence-led treatments delivered remotely

We help clinicians provide personalised care to more patients with less time.

  • Fully remote cardiovascular care
  • Reduced face-to-face appointments
  • Increased treatment adherence
  • Easy-to-read patient reports
  • Reduced workload
For payers & providers

For payers & providers

Better outcomes at less cost

We help practices digitise care pathways, optimise workload and reduce cost of care.

  • Digitally-enabled care pathways
  • Reduced hospital admissions
  • Real-world patient data & risk analysis
  • Increased nurse patient ratio
  • Cost saving from reduced disease burden

Programs

What we treat

Our treatment programs are evidence-based medical interventions that target the 4 most prevalent cardiovascular risk conditions.

The programs can be prescribed as standalone first-line behavioural therapy or combination therapy with medication.

Obesity

Reduce and maintain weight in CV risk patients

Dyslipidemia

Reduce LDL cholesterol and improve lipid balance

Hypertension

Reduce blood pressure in CV risk patients

Hyperglycemia

Reduce HbA1C and improve blood sugar control

Clinical Partners

Features

How it works

Assess

Personalised cardiovascular risk assessment

Learn

Interactive skill building and educational content to raise awareness and self-efficacy

Monitor

Fully remote monitoring of key biomarkers and lifestyle metrics

Engage

Gamified engagement system to raise patient activation and adherence

Treat

Clinical guideline based behavioral intervention programs

Share

Personal progress reports that can be shared with the care team

brand.name
Eno-Martin Lotman

“We are bridging the gap between clinical guidelines and human behavior”

Eno-Martin Lotman

Chief Medical Officer

Get started

Find out more

Patient

Be the first to get access when we launch.

Clinician

Find out how we can help you improve patient outcomes and save time.

Provider

Find out how we can help you improve patient outcomes and save time.

Payer

Find out how we can reduce the cost of care across your patient population.